Stocks
Atea ASAATAZF
OTCHealthcareBiotechnology$12.15-20.33%
Price as of · delayed, not real-time
Focused on developing antiviral therapies, this biopharmaceutical company specializes in treatments for RNA viruses including COVID-19 and hepatitis C. Investors monitor its clinical-stage pipeline and partnerships with larger pharma companies for commercialization.
Market Cap: $1.4B52W Range: $12.15 – $15.25
Congressional Interest in Atea ASA (ATAZF)
1 member of Congress has disclosed 1 trade in Atea ASA (ATAZF), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading ATAZF?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-09-28 | MICHAEL K. SIMPSON | sell | $1K – $15K |